Macrogenics MGNX
NASDAQ MGNX
$4.40 +0.15 (+3.53%)
At close: Sep 4, 2026 · 4:00 PM EDT

Macrogenics (MGNX) Change in Acquisitions & Divestments (2016 - 2026)

Macrogenics (MGNX) posted quarterly Change in Acquisitions & Divestments of $47.6 million for Q1 2026, up 159.69% year-over-year from $18.3 million in Q1 2025, and up 106.34% quarter-over-quarter from $23.1 million in Q4 2025.

Analysis

Macrogenics (MGNX) Change in Acquisitions & Divestments (2016 - 2026) Analysis & Trends

Macrogenics (MGNX) has reported Change in Acquisitions & Divestments for 11 consecutive years, with $47.6 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Change in Acquisitions & Divestments rose 159.69% year-over-year to $47.6 million; the TTM figure through Mar 2026 stood at $125.4 million (down 4.7% YoY), while the FY2025 annual figure was $96.1 million, down 49.41% from the prior year.
  • Change in Acquisitions & Divestments climbed to $47.6 million in Q1 2026 per MGNX's latest filing, from $23.1 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $76.8 million in Q1 2024 and bottomed at $8.6 million in Q2 2025.
  • Historically, Change in Acquisitions & Divestments has averaged $40.6 million across 5 years, with a median of $41.0 million in 2024.
  • Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments jumped 222.29% — and 2025, when it sank 84.77%.
  • Macrogenics' Change in Acquisitions & Divestments stood at $39.8 million in 2022, then jumped by 55.75% to $61.9 million in 2023, then tumbled by 74.36% to $15.9 million in 2024, then surged by 45.44% to $23.1 million in 2025, then surged by 106.34% to $47.6 million in 2026.
  • Business Quant data shows MGNX's Change in Acquisitions & Divestments at $47.6 million in Q1 2026, $23.1 million in Q4 2025, and $46.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Macrogenics 284.90 Mn 171.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 61.90 Mn
Mar 31, 2026 47.64 Mn
Dec 31, 2025 23.09 Mn
Sep 30, 2025 46.12 Mn
Jun 30, 2025 8.59 Mn
Mar 31, 2025 18.35 Mn
Dec 31, 2024 15.88 Mn
Sep 30, 2024 41.00 Mn
Jun 30, 2024 56.40 Mn
Mar 31, 2024 76.75 Mn
Dec 31, 2023 61.91 Mn
Sep 30, 2023 36.14 Mn
Jun 30, 2023 17.50 Mn
Mar 31, 2023 45.75 Mn
Dec 31, 2022 39.75 Mn
Sep 30, 2022 72.75 Mn
Jun 30, 2022 45.43 Mn
Mar 31, 2022 37.01 Mn
Dec 31, 2021 54.25 Mn
Sep 30, 2021 46.75 Mn